Alnylam Pharmaceuticals stock price
앨나일램 파머슈티컬스NASDAQ:ALNY · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Alnylam Pharmaceuticals last closed at $219.72 (-4.96%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 37.6×. Its overall grade ranks 428 of 739 stocks in Healthcare.
About this company
Alnylam Pharmaceuticals last closed at $219.72 (-4.96%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 428/739
Valuation grade F
Related stocks
- NovartisCompetitor
고지혈증·희귀질환 RNAi/약물 경쟁 가능성이 있는 대형 제약사
- Ionis PharmaceuticalsCompetitor
희귀질환·RNA 기반 치료제에서 직접 경쟁하는 대표 업체
- SanofiCustomer
Alnylam의 RNAi 치료제 공동개발·상업화 파트너로 매출/마일스톤 연결
ETFs holding this stock
T. Rowe Price Health Care ETF · iShares Biotechnology ETF · Invesco Nasdaq Biotechnology ETF
Details →About Alnylam Pharmaceuticals
- What technical signals does Alnylam Pharmaceuticals (ALNY) have?
- Alnylam Pharmaceuticals current technical signals: no active technical signal.
- Is Alnylam Pharmaceuticals a cup-and-handle pattern?
- No. Alnylam Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Alnylam Pharmaceuticals?
- Market cap: $29.03B. Trailing 12 months PER: 37.6×. Latest quarter PBR: 22.43×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-03 dataset
Turn what you saw on this name into a strategy
Ask Q about Alnylam Pharmaceuticals, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).